Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Clin J Gastroenterol ; 16(3): 361-365, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36735203

ABSTRACT

A 54-year-old man referred to our hospital for abdominal distension. He had no medical history. On physical examination, he complained lower abdominal distention, and had no spontaneous pain or tenderness. The blood tests showed that CEA and CA19-9 levels were within normal limits. Colonoscopy revealed a submucosal tumor with irregularities and mucosal defects in the descending colon. Computed tomography (CT) showed a 3-cm-diameter mass in the descending colon and ascites. Due to the presence of ascites, laparoscopic examination was performed, which revealed multiple peritoneal seeding of the tumor. Given the presence of peritoneal dissemination, the tumor was determined to be unresectable, and a histological examination was performed from the disseminated nodule. Pathologically, atypical spindle cells were observed and infiltrated into adipose tissue. Additional immunohistochemistry revealed positive expression for Murine double minute 2 (MDM2) and Cyclin-dependent kinase 4 (CDK4), and fluorescence in situ hybridization showed amplification of MDM2. Thus, the tumor was diagnosed with a dedifferentiated liposarcoma of the descending colon. Liposarcoma is a type of soft-tissue sarcoma that arises from soft tissues such as the extremities or retroperitoneum. Here, we report an extremely rare case of a dedifferentiated liposarcoma of the colon.


Subject(s)
Liposarcoma , Sarcoma , Male , Humans , Animals , Mice , Middle Aged , In Situ Hybridization, Fluorescence , Ascites , Colon, Descending/metabolism , Colon, Descending/pathology , Liposarcoma/diagnostic imaging , Liposarcoma/surgery
2.
World J Gastroenterol ; 26(3): 335-352, 2020 Jan 21.
Article in English | MEDLINE | ID: mdl-31988593

ABSTRACT

BACKGROUND: Obesity is a risk factor for colorectal cancer, yet metabolic distinctions between healthy right and left colon tissue, before cancer is diagnosed, remains largely unknown. This study compared right-ascending and left-descending colon tissue metabolomes to identify differences from the stool metabolome in normal weight, overweight, and obese adults. AIM: To examine right and left colon tissue metabolites according to body mass index that may serve as mechanistic targets for interventions and biomarkers for colon cancer risk. METHODS: Global, non-targeted metabolomics was applied to assess right-ascending and left-descending colon tissue collected from healthy adults undergoing screening colonoscopies to test the hypothesis that BMI differentially impacts colon tissue metabolite profiles. The colon tissue and stool metabolome of healthy adults (n = 24) was analyzed for metabolite signatures and metabolic pathway networks implicated in progression of colorectal cancer. RESULTS: Ascending and descending colon contained 504 host, food, and microbiota-derived metabolites from normal weight, overweight and obese adults grouped according to body mass index. Amino acids, lipids, and nucleotides were among the chemical types that further differentiated from the stool metabolite profiles. Normal weight adults had 46 significantly different metabolites between ascending and descending colon tissue locations, whereas there were 37 metabolite differences in overweight and 28 metabolite differences for obese adults (P < 0.05). Obese adults had trimethylamine N-oxide, endocannabinoids and monoacylglycerols with different relative abundances identified between ascending and descending colon. Primary and secondary bile acids, vitamins, and fatty acids also showed marked relative abundance differences in colon tissue from overweight/obese adults. CONCLUSION: There were metabolite profile differences between right-ascending and left-descending colon tissue in healthy adults. Colon lipids and other metabolites in obese and overweight adults were distinguished from normal weight participants and associated with gut inflammation, nutrient absorption, and products of microbiota metabolism.


Subject(s)
Colon, Ascending/metabolism , Colon, Descending/metabolism , Metabolome , Obesity/metabolism , Overweight/metabolism , Adult , Biomarkers, Tumor/metabolism , Body Mass Index , Colorectal Neoplasms/etiology , Feces/chemistry , Female , Gastrointestinal Microbiome/physiology , Healthy Volunteers , Humans , Ideal Body Weight/physiology , Intestinal Absorption/physiology , Lipid Metabolism , Lipids/analysis , Male , Middle Aged , Obesity/complications , Overweight/complications , Risk Factors
3.
Int J Mol Sci ; 20(5)2019 Feb 27.
Article in English | MEDLINE | ID: mdl-30818742

ABSTRACT

Neurons of the enteric nervous system (ENS) may undergo changes during maturation and aging, but knowledge of physiological stimuli-dependent changes in the ENS is still fragmentary. On the other hand, the frequency of many ENS-related intestinal illnesses depends on age and/or sex. The double immunofluorescence technique was used to study the influence of both of these factors on calcitonin gene-related peptide (CGRP)-positive enteric nervous structures-in the descending colon in young and adult female and castrated male pigs. The influence of age and gender on the number and neurochemical characterization (i.e., co-localization of CGRP with substance P, nitric oxide synthase, galanin, cocaine- and amphetamine-regulated transcript peptide and vesicular acetylcholine transporter) of CGRP-positive nerve structures in the colonic wall has been shown. These observations strongly suggest the participation of CGRP in adaptive processes in the ENS during GI tract maturation. Moreover, although the castration of males may mask some aspects of sex-dependent influences on the ENS, the sex-specific differences in CGRP-positive nervous structures were mainly visible in adult animals. This may suggest that the distribution and exact role of this substance in the ENS depend on the sex hormones.


Subject(s)
Aging/metabolism , Calcitonin Gene-Related Peptide/metabolism , Colon, Descending/metabolism , Neurons/metabolism , Sex Characteristics , Animals , Female , Galanin/metabolism , Male , Nerve Tissue Proteins/metabolism , Nitric Oxide Synthase Type I/metabolism , Substance P/metabolism , Swine , Vesicular Acetylcholine Transport Proteins/metabolism
4.
Neurogastroenterol Motil ; 30(11): e13439, 2018 11.
Article in English | MEDLINE | ID: mdl-30109906

ABSTRACT

BACKGROUND: The enteric nervous system (ENS), situated in the wall of the gastrointestinal tract, regulates the majority of intestinal activities in physiological conditions and during pathological processes. Enteric neurons are diversified in terms of active substance expression. One of the most important neuropeptides within the ENS is vasoactive intestinal polypeptide (VIP). It seems to be one among the important inhibitory peptides in addition to neuropeptide Y (NPY), nitric oxide (NO), and adenosine triphosphate (ATP) of the intestinal motility and secretion, however, many issues connected with distribution and roles of VIP in the large intestine, especially during pathological states, still remain unknown. METHODS: Changes in the VIP-like immunoreactivity of the enteric nervous structures under experimental pathological states, including chemically induced inflammation and nerve damage was examined using the double immunofluorescence technique with commercial antibodies. KEY RESULTS: Generally, both pathological factors studied caused an increase in the number of VIP-like immunoreactive (VIP-LI) neurons and nerve fibers, but the intensity of fluctuations depended on both the acting factor and the part of the ENS studied. CONCLUSIONS AND INFERENCES: The obtained results suggest that VIP participates in pathological processes concerning the digestive tract, and its exact functions probably depend on the type of damaging factor acting on the intestine.


Subject(s)
Colon, Descending/metabolism , Enteric Nervous System/metabolism , Inflammation/metabolism , Neurons/metabolism , Animals , Axotomy , Colon, Descending/pathology , Enteric Nervous System/pathology , Female , Inflammation/pathology , Neurons/pathology , Sus scrofa , Vasoactive Intestinal Peptide
5.
BMC Vet Res ; 14(1): 169, 2018 May 24.
Article in English | MEDLINE | ID: mdl-29793486

ABSTRACT

BACKGROUND: The enteric nervous system (ENS), located in the intestinal wall and characterized by considerable independence from the central nervous system, consists of millions of cells. Enteric neurons control the majority of functions of the gastrointestinal tract using a wide range of substances, which are neuromediators and/or neuromodulators. One of them is leucine-enkephalin (leuENK), which belongs to the endogenous opioid family. It is known that opioids in the gastrointestinal tract have various functions, including visceral pain conduction, intestinal motility and secretion and immune processes, but many aspects of distribution and function of leuENK in the ENS, especially during pathological states, remain unknown. RESULTS: During this experiment, the distribution of leuENK - like immunoreactive (leuENK-LI) nervous structures using the immunofluorescence technique were studied in the porcine colon in physiological conditions, during chemically-induced inflammation and after axotomy. The study included the circular muscle layer, myenteric (MP), outer submucous (OSP) and inner submucous plexus (ISP) and the mucosal layer. In control animals, the number of leuENK-LI neurons amounted to 4.86 ± 0.17%, 2.86 ± 0.28% and 1.07 ± 0.08% in the MP, OSP and ISP, respectively. Generally, both pathological stimuli caused an increase in the number of detected leuENK-LI cells, but the intensity of the observed changes depended on the factor studied and part of the ENS. The percentage of leuENK-LI perikarya amounted to 11.48 ± 0.96%, 8.71 ± 0.13% and 9.40 ± 0.76% during colitis, and 6.90 ± 0.52% 8.46 ± 12% and 4.48 ± 0.44% after axotomy in MP, OSP and ISP, respectively. Both processes also resulted in an increase in the number of leuENK-LI nerves in the circular muscle layer, whereas changes were less visible in the mucosa during inflammation and axotomy did not change the number of leuENK-LI mucosal fibers. CONCLUSIONS: LeuENK in the ENS takes part in intestinal regulatory processes not only in physiological conditions, but also under pathological factors. The observed changes are probably connected with the participation of leuENK in sensory and motor innervation and the neuroprotective effects of this substance. Differences in the number of leuENK-LI neurons during inflammation and after axotomy may suggest that the exact functions of leuENK probably depend on the type of pathological factor acting on the intestine.


Subject(s)
Colitis/veterinary , Colon, Descending/metabolism , Enkephalin, Leucine/metabolism , Swine Diseases/metabolism , Animals , Axotomy/veterinary , Colitis/metabolism , Colitis/physiopathology , Colon, Descending/innervation , Colon, Descending/physiology , Enkephalin, Leucine/physiology , Female , Fluorescent Antibody Technique/veterinary , Swine , Swine Diseases/physiopathology
6.
Toxins (Basel) ; 9(3)2017 03 10.
Article in English | MEDLINE | ID: mdl-28287437

ABSTRACT

The enteric nervous system (ENS) can undergo adaptive and reparative changes in response to physiological and pathological stimuli. These manifest primarily as alterations in the levels of active substances expressed by the enteric neuron. While it is known that mycotoxins can affect the function of the central and peripheral nervous systems, knowledge about their influence on the ENS is limited. Therefore, the aim of the present study was to investigate the influence of low doses of zearalenone (ZEN) and T-2 toxin on calcitonin gene related peptide-like immunoreactive (CGRP-LI) neurons in the ENS of the porcine descending colon using a double immunofluorescence technique. Both mycotoxins led to an increase in the percentage of CGRP-LI neurons in all types of enteric plexuses and changed the degree of co-localization of CGRP with other neuronal active substances, such as substance P, galanin, nitric oxide synthase, and cocaine- and amphetamine-regulated transcript peptide. The obtained results demonstrate that even low doses of ZEN and T-2 can affect living organisms and cause changes in the neurochemical profile of enteric neurons.


Subject(s)
Calcitonin Gene-Related Peptide/metabolism , Colon, Descending/drug effects , Neurons/drug effects , T-2 Toxin/toxicity , Zearalenone/toxicity , Animals , Colon, Descending/innervation , Colon, Descending/metabolism , Female , Neurons/metabolism , Nitric Oxide Synthase Type I/metabolism , Substance P/metabolism , Swine , Vesicular Acetylcholine Transport Proteins/metabolism
7.
Basic Clin Pharmacol Toxicol ; 119(6): 540-547, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27194111

ABSTRACT

The compound 5-fluorouracil (5-FU) is used in cancer chemotherapy and is known to cause diarrhoea. We recently reported that chemokine (C-X-C motif) ligand 1 (CXCL1) and neutrophils in the colonic mucosa were markedly increased by the administration of 5-FU in mice. Curcumin has anti-inflammatory, antitumour and antioxidant properties. Therefore, we examined the effect of curcumin on 5-FU-induced diarrhoea development and CXCL1 and CXCL2 up-regulation in the colon. Mice were given 5-FU (50 mg/kg, i.p.) daily for 4 days. Curcumin (100 or 300 mg/kg, p.o.) was administered on the day before the first administration of 5-FU and administered 30 min. before the administration of 5-FU. Gene expression levels of CXCL1 and CXCL2 in the colon were examined by real-time RT-PCR. Curcumin reduced the 5-FU-induced diarrhoea development. Under this condition, the CXCL1 and CXCL2 gene up-regulated by 5-FU administration was inhibited by curcumin. The gene expression of CXCL1 and CXCL2 was also enhanced by 5-FU application in vitro. The 5-FU-induced up-regulated CXCL1 and CXCL2 gene expressions were inhibited by curcumin, Bay-117082 and bortezomib, nuclear factor kappa B (NF-κB) inhibitors, C646, a p300/cyclic adenosine monophosphate response element-binding protein-histone acetyltransferase (HAT) inhibitor. In conclusion, these findings suggested that curcumin prevented the development of diarrhoea by inhibiting NF-κB and HAT activation.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Antioxidants/therapeutic use , Colon, Descending/drug effects , Curcumin/therapeutic use , Diarrhea/prevention & control , Dietary Supplements , Fluorouracil/adverse effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antimetabolites, Antineoplastic/chemistry , Antimetabolites, Antineoplastic/pharmacology , Antioxidants/administration & dosage , Antioxidants/pharmacology , Chemokine CXCL1/agonists , Chemokine CXCL1/antagonists & inhibitors , Chemokine CXCL1/genetics , Chemokine CXCL1/metabolism , Chemokine CXCL2/agonists , Chemokine CXCL2/antagonists & inhibitors , Chemokine CXCL2/genetics , Chemokine CXCL2/metabolism , Colon, Descending/immunology , Colon, Descending/metabolism , Colon, Descending/physiopathology , Curcumin/administration & dosage , Curcumin/pharmacology , Diarrhea/chemically induced , Diarrhea/metabolism , Diarrhea/physiopathology , E1A-Associated p300 Protein/agonists , E1A-Associated p300 Protein/antagonists & inhibitors , E1A-Associated p300 Protein/metabolism , Enzyme Inhibitors/pharmacology , Fluorouracil/antagonists & inhibitors , Fluorouracil/pharmacology , Gene Expression Regulation/drug effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestinal Mucosa/physiopathology , Male , Mice, Inbred C57BL , NF-kappa B/agonists , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Severity of Illness Index , Tissue Culture Techniques
8.
PLoS Pathog ; 10(6): e1004198, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24968145

ABSTRACT

Effective antiretroviral therapy (ART) dramatically reduces AIDS-related complications, yet the life expectancy of long-term ART-treated HIV-infected patients remains shortened compared to that of uninfected controls, due to increased risk of non-AIDS related morbidities. Many propose that these complications result from translocated microbial products from the gut that stimulate systemic inflammation--a consequence of increased intestinal paracellular permeability that persists in this population. Concurrent intestinal immunodeficiency and structural barrier deterioration are postulated to drive microbial translocation, and direct evidence of intestinal epithelial breakdown has been reported in untreated pathogenic SIV infection of rhesus macaques. To assess and characterize the extent of epithelial cell damage in virally-suppressed HIV-infected patients, we analyzed intestinal biopsy tissues for changes in the epithelium at the cellular and molecular level. The intestinal epithelium in the HIV gut is grossly intact, exhibiting no decreases in the relative abundance and packing of intestinal epithelial cells. We found no evidence for structural and subcellular localization changes in intestinal epithelial tight junctions (TJ), but observed significant decreases in the colonic, but not terminal ileal, transcript levels of TJ components in the HIV+ cohort. This result is confirmed by a reduction in TJ proteins in the descending colon of HIV+ patients. In the HIV+ cohort, colonic TJ transcript levels progressively decreased along the proximal-to-distal axis. In contrast, expression levels of the same TJ transcripts stayed unchanged, or progressively increased, from the proximal-to-distal gut in the healthy controls. Non-TJ intestinal epithelial cell-specific mRNAs reveal differing patterns of HIV-associated transcriptional alteration, arguing for an overall change in intestinal epithelial transcriptional regulation in the HIV colon. These findings suggest that persistent intestinal epithelial dysregulation involving a reduction in TJ expression is a mechanism driving increases in colonic permeability and microbial translocation in the ART-treated HIV-infected patient, and a possible immunopathogenic factor for non-AIDS related complications.


Subject(s)
Anti-HIV Agents/adverse effects , Colon/drug effects , Down-Regulation/drug effects , HIV Infections/drug therapy , Intestinal Mucosa/drug effects , Tight Junction Proteins/antagonists & inhibitors , Tight Junctions/drug effects , Academic Medical Centers , Anti-HIV Agents/therapeutic use , Cohort Studies , Colon/metabolism , Colon/pathology , Colon/virology , Colon, Ascending/drug effects , Colon, Ascending/metabolism , Colon, Ascending/pathology , Colon, Ascending/virology , Colon, Descending/drug effects , Colon, Descending/metabolism , Colon, Descending/pathology , Colon, Descending/virology , Colon, Transverse/drug effects , Colon, Transverse/metabolism , Colon, Transverse/pathology , Colon, Transverse/virology , Female , HIV Infections/metabolism , HIV Infections/pathology , HIV Infections/virology , Humans , Ileum/drug effects , Ileum/metabolism , Ileum/pathology , Ileum/virology , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/virology , Male , Middle Aged , Ohio , Organ Specificity , Permeability/drug effects , Tight Junction Proteins/genetics , Tight Junction Proteins/metabolism , Tight Junctions/metabolism , Tight Junctions/pathology , Tight Junctions/virology
9.
J Comp Pathol ; 150(2-3): 287-96, 2014.
Article in English | MEDLINE | ID: mdl-24650891

ABSTRACT

This study reports changes in expression of acetylcholine transferase (AChT) and nitric oxide synthetase (NOS) in neurons immunoreactive for cocaine- and amphetamine-regulated transcript (CART) peptides during chemically-driven inflammation and axotomy in the porcine descending colon. The co-localization of the neurotransmitters with CART was studied by double immunofluorescence in the myenteric plexus (MP) and outer submucosal plexus (OSP) of the porcine descending colon under physiological and selected pathological conditions. In control animals, neurons expressing CART also expressed AChT in 25.37 ± 0.98% and 26.73 ± 0.96% in the MP and OSP, respectively. Neuronal co-expression of CART with NOS occurred in 90.66 ± 2.13% and 88.09 ± 2.96% in the MP and OSP, respectively. Following axotomy the number of neurons co-expressing CART and AChT decreased to 16.50 ± 3.20% in the MP and increased to 35.49 ± 2.04% in the OSP, while the number of neurons co-expressing CART and NOS increased to 96.66 ± 2.38% in the MP and 97.46 ± 2.22% in the OSP. Experimentally-induced colitis resulted in an increase in the number of neurons co-expressing CART and AChT to 42.40 ± 2.28% in the MP and 63.62 ± 1.83% in the OSP. Similarly, in these animals the number of neurons co-expressing CART and NOS increased to 93.9 ± 2.58% in the MP and 90.43 ± 2.09% in the OSP. Sham-operated controls showed expression levels of 26.22 ± 0.66% (MP) and 27.02 ± 1.73% (OSP) for simultaneous CART and AChT expression and 94.18 ± 0.93% (MP) and 88.21 ± 0.81% (OSP) for CART and NOS co-localization. These data confirm that the examined neurotransmitters have a role in traumatic and inflammatory responses of enteric neurons.


Subject(s)
Choline O-Acetyltransferase/metabolism , Colon, Descending/metabolism , Inflammation/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Nitric Oxide Synthase/metabolism , Animals , Axotomy , Colon, Descending/pathology , Female , Inflammation/pathology , Myenteric Plexus/metabolism , Myenteric Plexus/pathology , Neurons/pathology , Submucous Plexus/metabolism , Submucous Plexus/pathology , Swine
10.
Histol Histopathol ; 28(7): 851-8, 2013 07.
Article in English | MEDLINE | ID: mdl-23277430

ABSTRACT

Cocaine- and amphetamine-regulated transcript peptide (CART) is a neuromediator and/or neuromodulator in nerve structures within the gastrointestinal tract, but knowledge about its distribution, functions and co-localisation with other neuronal factors, especially in humans, is very scarce. During the present investigation the distribution and immunohistochemical reaction (IR) of CART - like immunoreactive (CART-LI) nerve fibers in the circular muscle layer of human descending colon were studied. Fragments of human colon were processed for double labelling immunofluorescence using a mixture of anti-CART antibodies with antibodies against vesicular acetylocholine transporter (VAChT), vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase - activating peptide (PACAP), substance P (SP), galanin (GAL) and nitric oxide synthase (NOS). Thick CART-LI nerve fibers formed a very dense meshwork within the colonic circular muscle layer in all patients studied. The highest number of CART - positive nerves also contained VAChT and/or VIP. A slightly lower level of co-localisation was observed in the case of CART and PACAP or CART and NOS. Only single nerve fibers were concurrently immunoreactive to CART and SP or CART and GAL. The present study reports for the first time a detailed description of the IR of CART-LI nerve fibers in the circular muscle layer within adult human descending colon.


Subject(s)
Colon, Descending/metabolism , Gene Expression Regulation , Muscle, Smooth/metabolism , Nerve Fibers/metabolism , Nerve Tissue Proteins/metabolism , Aged , Female , Galanin/metabolism , Humans , Immunohistochemistry , Male , Middle Aged , Neurons/metabolism , Nitric Oxide Synthase/metabolism , Pituitary Adenylate Cyclase-Activating Polypeptide/metabolism , Substance P/metabolism , Vasoactive Intestinal Peptide/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism
11.
Br J Nutr ; 109(1): 33-42, 2013 Jan 14.
Article in English | MEDLINE | ID: mdl-22716201

ABSTRACT

The present study aimed to explore the role(s) of the soya isoflavone genistein (GEN) in preventing the development of colon pre-neoplasia, using Wingless/int (WNT)/ß-catenin as a molecular marker of colon abnormality. Specifically, the effects on the WNT/ß-catenin signalling pathway from GEN were examined by using an azoxymethane (AOM)-induced rat colon cancer model. Male Sprague-Dawley rats were fed a control (CTL), a soya protein isolate (SPI) or a GEN diet from gestation to 13 weeks of age. The first sampling was conducted at 7 weeks of age for pre-AOM analysis. The remaining rats were injected with AOM at 7 weeks of age. The descending colon was collected 6 weeks later for the evaluation of aberrant crypt foci (ACF), gene expression and nuclear protein accumulation. AOM injection induced aberrant nuclear accumulation of ß-catenin in the CTL group but not in the SPI or GEN group. Moreover, the WNT target genes Cyclin D1 and c-Myc were repressed by SPI and GEN. Meanwhile, SPI and GEN suppressed the expression of WNT signalling genes including Wnt5a, Sfrp1, Sfrp2 and Sfrp5 to the similar level to that of the pre-AOM period. Rats fed SPI and GEN had a decreased number of total aberrant crypts. GEN feeding also resulted in a reduced number of ACF with N = 3 per foci. The reduction of WNT/ß-catenin signalling was correlated with the decrease in total aberrant crypts. By testing WNT/ß-catenin signalling as a biomarker of colon carcinogenic potential, we showed the novel role of GEN as a suppressor of carcinogen-induced WNT/ß-catenin signalling in preventing the development of early colon neoplasia.


Subject(s)
Colon, Descending/metabolism , Colonic Neoplasms/prevention & control , Disease Models, Animal , Down-Regulation , Genistein/therapeutic use , Precancerous Conditions/prevention & control , Wnt Signaling Pathway , Aberrant Crypt Foci/metabolism , Aberrant Crypt Foci/pathology , Aberrant Crypt Foci/prevention & control , Animals , Azoxymethane , Biomarkers/metabolism , Carcinogens , Colon, Descending/pathology , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cyclin D1/genetics , Cyclin D1/metabolism , Female , Genistein/metabolism , Lactation , Male , Maternal Nutritional Physiological Phenomena , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Pregnancy , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , Rats , Rats, Sprague-Dawley , Soybean Proteins/metabolism , Soybean Proteins/therapeutic use
12.
Eur J Pharmacol ; 667(1-3): 365-74, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21723862

ABSTRACT

The aim of this study was to investigate whether the pig colon descendens might be a good model for the responses mediated via the different locations of human colonic 5-HT(4) receptors. The intrinsic excitatory and inhibitory motor neurotransmission in pig colon descendens was therefore first characterized. In circular smooth muscle strips, electrical field stimulation (EFS) at basal tone induced only in the combined presence of the NO synthase inhibitor N(ω)-nitro-L-arginine methyl ester hydrochloride (L-NAME) and the SK channel blocker apamin voltage-dependent on-contractions. These on-contractions were largely reduced by the neuronal conductance blocker tetrodotoxin (TTX) and by the muscarinic receptor antagonist atropine, illustrating activation of cholinergic neurons. The 5-HT(4) receptor agonist prucalopride facilitated submaximal EFS-evoked cholinergic contractions and this effect was prevented by the 5-HT(4) receptor antagonist GR113808, supporting the presence of facilitating 5-HT(4) receptors on the cholinergic nerve endings innervating circular muscle in pig colon descendens. Relaxations were induced by EFS in strips pre-contracted with substance P in the presence of atropine. The responses at lower stimulation voltages were abolished by TTX. L-NAME or apamin alone did not influence or only moderately reduced the relaxations, but L-NAME plus apamin abolished the relaxations at lower stimulation voltages, suggesting that NO and ATP act as inhibitory neurotransmitters in a redundant way. Prucalopride did not influence the EFS-induced relaxations at lower stimulation voltage, nor did it per se relax contracted circular muscle strips. No evidence for relaxing 5-HT(4) receptors, either on inhibitory neurons or on the muscle cells was thus obtained in pig colon descendens circular muscle.


Subject(s)
Colon, Descending/physiology , Motor Neurons/cytology , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Receptors, Serotonin, 5-HT4/metabolism , Swine , Synaptic Transmission , Animals , Benzofurans/pharmacology , Choline/metabolism , Colon, Descending/drug effects , Colon, Descending/metabolism , Electric Stimulation , In Vitro Techniques , Male , Motor Neurons/drug effects , Motor Neurons/metabolism , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Muscle, Smooth/metabolism , Nitric Oxide/biosynthesis , Serotonin/pharmacology , Serotonin 5-HT4 Receptor Agonists/pharmacology , Synaptic Transmission/drug effects
13.
Exp Mol Pathol ; 90(1): 13-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21110956

ABSTRACT

Sympathetic neurons are capable of extensive regeneration following axonal injury. To investigate the response to axotomy of colon-projecting neurons (CPN) localized in the porcine sympathetic chain ganglia (SChG), the retrograde Fast Blue (FB) tracer, axonal transection and double immunohistochemistry methods were applied. The CPN were localized exclusively in the lumbar SChG and displayed a predominantly catecholaminergic [i.e. Tyrosine Hydroxylase (TH)/Dopamine ß Hydroxylase (DßH)] and Neuropeptide Y (NPY) positive phenotype under physiological conditions. Axotomy led to a significant decrease in TH/DßH production and a simultaneous increase in the neuropeptides Galanin (GAL) and Somatostatin (SOM), but not NPY or Vasoactive Intestinal Peptide (VIP) expression in retrogradely traced perikarya. Furthermore, the decrease in density of TH-/DßH-, VIP-, Leu(5)-Enkephalin (LENK)-, Choline Acetyltransferase (ChAT)-immunoreactive (-IR) nerve fibers occurred after axotomy. These data suggest a species-specific response to axonal damage of the CPN localized in porcine SChG. Since the SChG neurons supervise the vasculature of gut both in physiological and pathological conditions, and since pig is a more accurate animal model of human gut than a rodent (Swindle et al., 1992), these data may contribute to the understanding of the pathology of several gut illnesses, like Crohn Disease and Irritable Bowel Syndrome which commonly affect western populations.


Subject(s)
Colon, Descending/innervation , Ganglia, Sympathetic/physiology , Neuronal Plasticity/physiology , Sus scrofa , Animals , Axotomy , Choline O-Acetyltransferase/metabolism , Colon, Descending/metabolism , Dopamine beta-Hydroxylase/metabolism , Galanin/metabolism , Models, Animal , Nerve Fibers/metabolism , Neuropeptide Y/metabolism , Random Allocation , Somatostatin/metabolism , Tyrosine 3-Monooxygenase/metabolism , Vasoactive Intestinal Peptide/metabolism
14.
Scand J Gastroenterol ; 45(11): 1320-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20446826

ABSTRACT

OBJECTIVES: The APC gene mutation triggers familial adenomatous polyposis (FAP) and approximately 80% of sporadic colorectal cancers. FAP summarizes the natural history of colorectal cancer because low- and high-grade dysplastic lesions and adenocarcinoma are simultaneously present in the same patients free from individual and environmental variability factors. Estrogen receptor beta (ERß) has recently been suggested as the most likely mediator of estrogen-related anti-carcinogenic effects in Apc(Min-/+) mice and humans. In this study we assessed the ERß expression in the intestinal mucosa of FAP patients to verify its possible involvement in tumor progression in colorectal cancer. MATERIAL AND METHODS: ERß and ERα expression, cell proliferation (Ki-67) and apoptosis (TUNEL), were evaluated on archival biopsy material from six patients with FAP who underwent colectomy. RESULTS: A progressive significant decrease of ERß expression was observed in the different stages of the disease as compared to normal mucosa (p < 0.001). Interestingly, a decreased ERß expression was directly correlated with apoptosis (r = 0.76, p < 0.001), and inversely correlated with cell proliferation (r = 0.54, p < 0.05). CONCLUSIONS: ERß expression is related to the severity of the disease, supporting the role of ERß as a relevant biomarker of tumor progression and possible chemopreventive target in patients at risk of colonic neoplasia.


Subject(s)
Adenocarcinoma/genetics , Adenomatous Polyposis Coli/genetics , Colon, Descending/metabolism , Colorectal Neoplasms/genetics , DNA, Neoplasm , Estrogen Receptor beta/genetics , Gene Expression Regulation, Neoplastic , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenomatous Polyposis Coli/metabolism , Adenomatous Polyposis Coli/pathology , Adult , Apoptosis , Biopsy , Cell Proliferation , Colon, Descending/cytology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Disease Progression , Estrogen Receptor beta/biosynthesis , Female , Humans , In Situ Nick-End Labeling , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Prognosis , Severity of Illness Index
15.
J Pharm Pharmacol ; 62(3): 389-92, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20487224

ABSTRACT

OBJECTIVES: Intestinal bacteria are thought to be involved in the initiation and perpetuation of inflammatory bowel diseases. Prebiotics (non-digestable dietary carbohydrate) have beneficial properties that alter the intestinal flora and contain glutamine-rich protein. Glutamine significantly decreases indices of inflammation. In this study, an enzymatic hydrolysate of corn gluten (EHCG) was administered by gavage to Sprague-Dawley rats fed an elemental diet to determine whether EHCG can ameliorate experi- mental colitis. METHODS: Colitis was induced by intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid after 10 days' daily oral administration of EHCG at 100 and 300 mg/kg. Macroscopic damage was assessed using a scoring system. The mucosa homogenate was sonicated and myeloperoxidase activity and histamine levels measured. KEY FINDINGS: Treatment with EHCG significantly decreased the severity of injury and reduced myeloperoxidase activity and histamine levels in the distal colon mucosa. CONCLUSIONS: EHCG may have therapeutic benefit as a supplement in enteral nutrition for patients with inflammatory bowel diseases.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Colitis/prevention & control , Glutens/metabolism , Protein Hydrolysates/therapeutic use , Seeds/chemistry , Zea mays/chemistry , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Colitis/chemically induced , Colitis/pathology , Colon, Descending/drug effects , Colon, Descending/metabolism , Colon, Descending/pathology , Dietary Supplements , Disease Models, Animal , Dose-Response Relationship, Drug , Food, Formulated/adverse effects , Histamine/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Peroxidase/metabolism , Protein Hydrolysates/administration & dosage , Rats , Rats, Sprague-Dawley , Severity of Illness Index , Trinitrobenzenesulfonic Acid/toxicity
16.
Exp Mol Pathol ; 88(3): 416-23, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20138863

ABSTRACT

This study reports on changes in the somatostatin-like immunoreactive (SOM-LI) nerve structures of the enteric nervous system (ENS) in the porcine descending colon, caused by chemically driven inflammation, proliferative enteropathy (PE), which is a "natural" inflammation with proliferative changes and nerve injury (axotomy). The distribution pattern of SOM-LI structures was studied using the immunofluorescence technique in the circular muscle layer, the myenteric (MP), outer submucous (OSP) and inner submucous plexuses (ISP) and also in the mucosal layer. Under physiological conditions SOM-LI perikarya have been shown to constitute 1.97+/-0.36%, 2.06+/-0.33% and 4.23+/-0.40% in the MP, OSP and ISP, respectively. Changes in SOM-immunoreactivity depended on the pathological factor and the part of the ENS studied. Numbers of the SOM-LI perikarya amounted 1.81+/-0.30, 1.97+/-0.24 and 11.15+/-0.95 during chemically induced colitis and 3.21+/-0.37%, 4.33+/-0.33% and 4.42+/-0.32% after axotomy in MP, OSP and ISP, respectively. Moreover during PE SOM-positive cell bodies were not observed at all in MP, whereas within OSP and ISP the number of SOM-LI perikarya amounted to 3.34+/-0.36 and 10.92+/-059, respectively. All processes studied resulted in a decrease in the number of SOM-LI nerve fibers in the mucosal layer, whereas within the circular muscle layer chemically induced inflammation and axotomy caused an increase in the number of the SOM-LI nerve fibers contrary to PE, which reduced the number of such fibers. The obtained results suggest that SOM-LI nerve structures of the ENS may participate in various pathological states within the porcine descending colon and their functions probably depend on the type of pathological factor.


Subject(s)
Colon, Descending/innervation , Colon, Descending/metabolism , Enteric Nervous System/metabolism , Peptides/metabolism , Animals , Colitis/metabolism , Colitis/pathology , Colon, Descending/pathology , Desulfovibrionaceae Infections/metabolism , Desulfovibrionaceae Infections/pathology , Enteric Nervous System/pathology , Female , Immunohistochemistry , Myenteric Plexus/metabolism , Myenteric Plexus/pathology , Submucous Plexus/metabolism , Submucous Plexus/pathology , Sus scrofa
17.
Eur J Gastroenterol Hepatol ; 22(5): 614-9, 2010 May.
Article in English | MEDLINE | ID: mdl-20173645

ABSTRACT

OBJECTIVE: This study aimed at investigating whether a differential estrogen receptor beta (ER-beta) expression between the colonic subsites could correspond to a modification in proliferation, apoptosis, and adhesion of the normal colonocytes. METHODS: ER-beta, Ki-67, Bcl-2, and E-cadherin expressions were investigated immunohistochemically, in normal epithelium biopsies from the ascending and the descending colon of 53 individuals, who underwent colonoscopy for the investigation of anemia and in whom no local pathology was identified. RESULTS: ER-beta immunoreactivity has been shown to be stronger at the superficial epithelium than the crypts' base, the difference being important only for the ascending colon. In addition, ER-beta expression was higher in the superficial epithelium of the ascending colon than that of the descending colon. The variations of ER-beta expression did not correspond to the alterations in Ki-67, Bcl-2, and E-cadherin expression. CONCLUSION: A subsite-specific variation of ER-beta expression has been shown in the normal colonic epithelium. This modulation of ER-beta might account for some well established specificities of colorectal cancer epidemiology like the right-sided predominance of the neoplasm in women and its gradual shift to more proximal sites over time.


Subject(s)
Colon, Ascending/metabolism , Colon, Descending/metabolism , Colorectal Neoplasms/metabolism , Estrogen Receptor beta/metabolism , Intestinal Mucosa/metabolism , Adult , Aged , Apoptosis/physiology , Biopsy , Cell Adhesion/physiology , Cell Division/physiology , Colon, Ascending/pathology , Colon, Descending/pathology , Colonoscopy , Colorectal Neoplasms/pathology , Female , Humans , Immunohistochemistry , Intestinal Mucosa/pathology , Male , Middle Aged , Reference Values
18.
Peptides ; 30(12): 2213-20, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19778563

ABSTRACT

Plasma and tissue profiles of gastrointestinal hormones ghrelin and peptide YY (PYY) were investigated in different female rat reproductive states. Neither plasma nor tissue ghrelin concentrations were suppressed during pregnancy despite elevated leptin. The highest concentrations of stomach ghrelin were measured in late pregnancy. PYY concentrations in plasma, descending colon and rectum tissues were increased (P<0.001) throughout pregnancy and lactation. PYY peaked at day 5 of lactation in plasma, as well as descending colon and rectum tissues (proestrus vs day 5 of lactation: 25+/-3.0 pmol/l vs 55+/-8.0 pmol/l; 85+/-4.5 pmol/g wwt vs 418+/-45.0 pmol/g wwt; 23+/-3.0 pmol/g wwt vs 78+/-9.1 pmol/g wwt). This PYY peak was temporally associated with the luteinizing hormone peak on day 1 of lactation. Following weaning, dam adiposity and plasma leptin increased whereas ghrelin stomach peptide decreased. Relative PYY concentrations in the tissues of the gut varied in the different states suggesting regional alterations taking place in the colon. The ascending colon produced the highest concentrations in non-pregnant rats, the descending colon the highest concentrations during lactation with the pregnant rats and the dams postweaning in a transition state between. It is unclear what role the increased PYY in various tissues observed has during pregnancy and lactation as it would be expected to be reduced in these states of greatly increased appetite. PYY may have an influence on maternal dietary adaptation, intestinal hypertrophy and weight gain during pregnancy and lactation although it is still unclear precisely how it acts.


Subject(s)
Gastric Mucosa/metabolism , Ghrelin/blood , Ghrelin/metabolism , Lactation/blood , Lactation/metabolism , Peptide YY/blood , Peptide YY/metabolism , Animals , Colon, Ascending/metabolism , Colon, Descending/metabolism , Female , Ileum/metabolism , Leptin/blood , Luteinizing Hormone/blood , Pregnancy , Progesterone/blood , Prolactin/blood , Rats , Rectum/metabolism
19.
Scand J Gastroenterol ; 42(7): 834-40, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17558907

ABSTRACT

OBJECTIVE: Responses and adverse events to medication vary greatly among patients with Crohn's disease (CD). The aim of this study was to investigate whether global gene expression profiles could predict such responses and possible side effects. MATERIAL AND METHODS: Tissue specimens from the descending colon were obtained from 32 CD patients (in 18 patients from areas without inflammation and in 14 patients from inflamed areas). Gene profiling was done using the Affymetrix Human Genome U133 Plus 2.0 GeneChip array. Hybridization data were analyzed with dChip software. RESULTS: There were no differentially expressed genes between six patients who responded well to azathioprine and four who did not. No differences were found between 12 patients with adverse events to azathioprine and 9 patients who tolerated this drug. Sixteen patients who were not glucocorticoid-dependent had no differentially expressed genes as compared with 15 glucocorticoid-dependent patients. Six patients who responded well to infliximab had only one differentially expressed gene as compared to four patients who did not. CONCLUSIONS: DNA microarray analyses did not show differentially expressed genetic profiles from colonic mucosal cells obtained from groups of patients classified according to therapeutic criteria.


Subject(s)
Azathioprine/therapeutic use , Crohn Disease/genetics , Gene Expression , Immunosuppressive Agents/therapeutic use , Oligonucleotide Array Sequence Analysis , Adolescent , Adult , Azathioprine/adverse effects , Cluster Analysis , Colon, Descending/metabolism , Colonoscopy , Crohn Disease/drug therapy , Crohn Disease/metabolism , Female , Gene Expression Profiling , Glucocorticoids/therapeutic use , Humans , Immunosuppressive Agents/adverse effects , Intestinal Mucosa/metabolism , Male , Middle Aged , Nucleic Acid Hybridization , Pharmacogenetics , Prognosis
20.
Neuroscience ; 147(1): 164-73, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17509768

ABSTRACT

N-methyl-D-aspartate (NMDA) receptors and the expression of their different splice variants and subunits were previously characterized in the brain and spinal cord. However, knowledge on the NMDA receptor expression and function in the enteric nervous system is limited. Previous work suggested that NMDA receptors were involved in a rat model of visceral hypersensitivity. The aim of this study was to characterize the expression of the NMDA receptor NR1 splice variants and the NR2 subunit subtypes in the rat colon. We visualized the expression of NR1 protein in the rat submucosal and myenteric plexuses. The NR1 splice variants found in the colon of rats lacked the N1 and C1 cassettes and contained the C2 and C2' cassettes (NR1(000) and NR1(001)). The NR2B and NR2D subunits were also found in the rat colon. Moreover, NMDA receptors in the rat colon were heteromeric, since NR1 was co-localized with NR2B and NR2D subunits using fluorescent immunohistochemistry. The identification of the NMDA receptors in the enteric nervous system could lead to the development of drugs that selectively modulate bowel function.


Subject(s)
Colon, Descending/metabolism , Myenteric Plexus/metabolism , Protein Subunits/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Submucous Plexus/metabolism , Animals , Brain/metabolism , Immunohistochemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Subunits/classification , Protein Subunits/genetics , RNA/analysis , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...